Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy

被引:116
|
作者
Hamblin, Milton
Friedman, David B.
Hill, Salisha
Caprioli, Richard M.
Smith, Holly M.
Hill, Michael F.
机构
[1] Meharry Med Coll, Dept Biomed Sci, Div Cardiovasc Biol, Nashville, TN 37208 USA
[2] Vanderbilt Univ, Dept Biochem, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
antioxidants; cardiomyopathy; diabetes mellitus; heart failure; oxidative stress; proteomics; ventricular function;
D O I
10.1016/j.yjmcc.2006.12.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic cardiomyopathy has been documented as an underlying etiology of heart failure (HF) among diabetics. Although oxidative stress has been proposed to contribute to diabetic cardiomyopathy, much of the evidence lacks specificity. Furthermore, whether alterations occur at the cardiac proteome level in diabetic cardiac complications with attendant oxidative stress remains unknown. Therefore, we sought to identify cardiac protein changes in relation to myocardial oxidative stress that are specific to diabetic cardiomyopathy. Diabetes was induced in rats by a single injection of streptozotocin (STZ). STZ-treated rats were examined for diabetic cardiomyopathy at 8 weeks post-STZ by left ventricular (LV) hemodynamic analysis. LV systolic pressure (LVSP), rate of pressure rise (+dP/dt), and rate of pressure decay (-dP/dt) were depressed while LV end-diastolic pressure (LVEDP) was increased. Myocardial oxidative stress was increased in STZ-diabetic rats, as indexed by significant increases in myocardial formation of 8-iso PGF2 alpha and oxidized glutathione (GSSG). In-depth mining of the diabetic myocardial proteome by proteomic analysis utilizing two-dimensional difference gel electrophoresis and mass spectrometry (DIGE/MS) techniques revealed that a high proportion (12 of 24) of the altered proteins that could be identified by mass spectrometry were localized to the mitochondria. Down-regulation of antioxidant and anti-apoptotic proteins was also observed in STZ-diabetic hearts. These results characterize a specific 'type I diabetic' pattern of cardiac proteome changes indicative of diabetic cardiomyopathy presenting with higher oxidative stress, supporting the idea that analysis of isoprostane biosynthesis and protein expression profiles may be useful diagnostically to assess the efficacy of antioxidant therapies as prophylactic treatments against type I diabetes mellitus complications involving the heart. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:884 / 895
页数:12
相关论文
共 50 条
  • [1] Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy
    Du, Shuqin
    Shi, Hanqiang
    Xiong, Lie
    Wang, Ping
    Shi, Yanbo
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [2] Oxidative stress and myocardial injury in the diabetic heart
    Ansley, David M.
    Wang, Baohua
    JOURNAL OF PATHOLOGY, 2013, 229 (02): : 232 - 241
  • [3] Tongmai Hypoglycemic Capsule Attenuates Myocardial Oxidative Stress and Fibrosis in the Development of Diabetic Cardiomyopathy in Rats
    ZENG Jieqiong
    ZHOU Huifen
    DU Haixia
    WU Yujia
    MAO Qianping
    YIN Junjun
    WAN Haitong
    YANG Jiehong
    Chinese Journal of Integrative Medicine, 2025, 31 (03) : 251 - 260
  • [4] HYDROGEN SULFIDE ATTENUATES MYOCARDIAL APOPTOSIS THROUGH SUPPRESSING OXIDATIVE STRESS IN DIABETIC CARDIOMYOPATHY RATS
    Li, F.
    Wu, Z. X.
    Luo, J.
    Xiao, T.
    Zeng, O.
    Li, L.
    Li, Y.
    Yang, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 : 6 - 7
  • [5] Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy
    Lei, Xiao-Tian
    Pu, Dan-Lan
    Shan, Geng
    Wu, Qi-Nan
    WORLD JOURNAL OF DIABETES, 2024, 15 (06)
  • [6] Tongmai Hypoglycemic Capsule Attenuates Myocardial Oxidative Stress and Fibrosis in the Development of Diabetic Cardiomyopathy in Rats
    Zeng, Jie-qiong
    Zhou, Hui-fen
    Du, Hai-xia
    Wu, Yu-jia
    Mao, Qian-ping
    Yin, Jun-jun
    Wan, Hai-tong
    Yang, Jie-hong
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2025, 31 (03) : 251 - 260
  • [7] The myocardial and vascular pathology of diabetic cardiomyopathy
    Hardin, NJ
    CORONARY ARTERY DISEASE, 1996, 7 (02) : 99 - 108
  • [8] Alterations in Myocardial Metabolism in the Diabetic Myocardium
    Lazar, Harold L.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2006, 18 (04) : 289 - 292
  • [9] DIABETIC MYOCARDIAL ALTERATIONS IN ULTRASTRUCTURE AND FUNCTION
    KOLTAI, MZ
    BALOGH, I
    WAGNER, M
    POGATSA, G
    EXPERIMENTAL PATHOLOGY, 1984, 25 (04): : 215 - 221
  • [10] Effects of atorvastatin on myocardial oxidative and nitrosative stress in diabetic rats
    Yaribeygi H.
    Faghihi N.
    Mohammadi M.T.
    Sahebkar A.
    Comparative Clinical Pathology, 2018, 27 (3) : 691 - 697